International Conference on Bioinformatics, Biomedicine, Biotechnology and Computational Biology
June 10, 2024
Detroit,United States of America
The Eurasia International Conference on Bioinformatics, Biomedicine, Biotechnology, and Computational Biology (EUIC3BCB - 2024) will be hosted in Detroit, USA, on 8th-9th June 2024. This conference serves as a recurring interactive platform for global professionals to discuss advancements in these fields. Participants exploring career opportunities or professional ties are welcome. It acts as an ideal forum for networking and relationship building. The event facilitates knowledge exchange among professionals involved in Bioinformatics, Biomedicine, Biotechnology, and Computational Biology, showcasing technological advancements and solutions used worldwide. Stakeholders from research, academia, industry, and government sectors convene, fostering collaboration and sharing insights into current practices and advancements in Biotechnology.
The 62nd Annual PTCOG Conference invites you to join the foremost innovators and thought leaders in the field of particle therapy. This premier event offers a gateway to the latest advancements, networking, and professional growth in cancer treatment. PTCOG boasts 16 active Sub-Committees, fostering collaboration and reporting on their activities. This year, the Scholar-in-Training (SIT) Sub-Committee contributes to educational and scientific program planning, engaging younger generations in leadership. Discussions include funding for research projects and the future of the International Journal of Particle Therapy. Join us from June 10 to June 15, 2024, to be part of the PTCOG community dedicated to advancing particle therapy.
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our